Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost cardiovascular risk.

Show notes
(00:31)
Could you provide us a little bit about your background?

(01:20)
Could you give us a brief overview of this assay?

(02:45)
What patients should have this test and when should it be performed?

(04:25)
Could you talk a little bit about alternative test options and how they compare to our ceramides test?

(05:58)
Can you go a little bit further into how these results can impact patient care and how you may monitor patients in the future with this testing?